Evidence map›Paper›PMID 33378351›Full record

ArticlePloS one2020

Characterization of ecotin homologs from Campylobacter rectus and Campylobacter showae.

Cody Thomas, Harald Nothaft, Ruchi Yadav, Christopher Fodor, Abofu Alemka, Oluwadamilola Oni, Michael Bell, Balázs Rada, Christine M Szymanski

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Cody ThomasDepartment of Microbiology and Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia, United States of America.ORCID 0000-0001-8891-9131
Harald NothaftDepartment of Biological Sciences, University of Alberta, Edmonton, Alberta, Canada.ORCID 0000-0003-3542-7840
Ruchi YadavDepartment of Infectious Diseases, University of Georgia, Athens, Georgia, United States of America.
Christopher FodorDepartment of Biological Sciences, University of Alberta, Edmonton, Alberta, Canada.
Abofu AlemkaDepartment of Biological Sciences, University of Alberta, Edmonton, Alberta, Canada.
Oluwadamilola OniDepartment of Infectious Diseases, University of Georgia, Athens, Georgia, United States of America.
Michael BellDepartment of Infectious Diseases, University of Georgia, Athens, Georgia, United States of America.
Balázs RadaDepartment of Infectious Diseases, University of Georgia, Athens, Georgia, United States of America.ORCID 0000-0002-9742-4955
Christine M SzymanskiDepartment of Microbiology and Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia, United States of America.ORCID 0000-0002-8464-1352
University of Georgia · USUniversity of Alberta · CA

Funding

Neutrophil extracellular traps in cystic fibrosisR01HL136707 · NHLBI · UNIVERSITY OF GEORGIA · PI RADA, BALAZS · 2018 to 2021
$2.6M
NHLBI NIH HHS R01 HL136707
6 · The paper itself

Abstract

Ecotin, first described in Escherichia coli, is a potent inhibitor of a broad range of serine proteases including those typically released by the innate immune system such as neutrophil elastase (NE). Here we describe the identification of ecotin orthologs in various Campylobacter species, including Campylobacter rectus and Campylobacter showae residing in the oral cavity and implicated in the development and progression of periodontal disease in humans. To investigate the function of these ecotins in vitro, the orthologs from C. rectus and C. showae were recombinantly expressed and purified from E. coli. Using CmeA degradation/protection assays, fluorescence resonance energy transfer and NE activity assays, we found that ecotins from C. rectus and C. showae inhibit NE, factor Xa and trypsin, but not the Campylobacter jejuni serine protease HtrA or its ortholog in E. coli, DegP. To further evaluate ecotin function in vivo, an E. coli ecotin-deficient mutant was complemented with the C. rectus and C. showae homologs. Using a neutrophil killing assay, we demonstrate that the low survival rate of the E. coli ecotin-deficient mutant can be rescued upon expression of ecotins from C. rectus and C. showae. In addition, the C. rectus and C. showae ecotins partially compensate for loss of N-glycosylation and increased protease susceptibility in the related pathogen, Campylobacter jejuni, thus implicating a similar role for these proteins in the native host to cope with the protease-rich environment of the oral cavity.

Indexed as

AnimalsCampylobacterCampylobacter rectusCells, CulturedChickensEscherichia coli ProteinsHumansNeutrophilsPancreatic ElastasePeriplasmic ProteinsSequence HomologySerine Proteinase InhibitorsTrypsin InhibitorsEco protein, E coliEscherichia coli ProteinsPancreatic ElastasePeriplasmic ProteinsSerine Proteinase InhibitorsTrypsin Inhibitors

Identifiers

PMID33378351
PMCPMC7773321
OpenAlexW3115332782

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.